Latest Schedule 13G passive stakes

Deep Track Capital, LP, along with affiliated entities, has disclosed a beneficial ownership of 7.45% of Nurix Therapeutics, Inc. common stock as of June 30, 2026.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 4.9% of Tonix Pharmaceuticals Holding Corp. common stock, including shares issuable upon warrant exercise.

American Century entities and Stowers Institute report updated beneficial ownership of Spectrum Brands Holdings common stock.

Sirenia Capital Management LP and Alex Silverstein have reported a 0% beneficial ownership of Q32 Bio Inc. common stock, indicating a full divestment.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 6.1% of InflaRx N.V.'s ordinary shares.

Deep Track Capital, along with affiliated entities, has reported beneficial ownership of 8.33% of X4 Pharmaceuticals' common stock as of June 30, 2026.

American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively increased their beneficial ownership of OneWater Marine Inc. Class A Common Stock to 7.0% and 13.0% respectively.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 4.3% of Immunome Inc.'s common stock as of June 30, 2026.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 7.2% of First Tracks Biotherapeutics, Inc. common stock.

Several American Century entities have amended their Schedule 13G filing, reporting changes in their beneficial ownership of Kohl's Corporation common stock.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 3.1% of Dianthus Therapeutics, Inc. common stock, including shares issuable from options.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 3,592,740 shares, representing 3.25% of Viridian Therapeutics, Inc.'s common stock.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 9.5% of Design Therapeutics, Inc. common stock.

Several American Century entities and the Stowers Institute for Medical Research have updated their beneficial ownership filings for Infinity Natural Resources, Inc., reporting significant stakes.

Investment firm Deep Track Capital, through its associated entities, has reported beneficial ownership of 4,000,000 shares, representing 3.82% of Personalis, Inc.'s common stock.

Sirenia Capital Management LP and Alex Silverstein have reported a beneficial ownership of 4.8% in Cybin Inc. common shares, including shares issuable upon warrant exercise.

American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have jointly filed a Schedule 13G, reporting a combined beneficial ownership of 11.8% of Entravision Communications Corporation's Class A Common Stock.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 5.0% of AnaptysBio, Inc. common stock as of June 30, 2026.

Oasis Management Company Ltd. and Seth Fischer have reported beneficial ownership of 2,329,018 shares, representing 6.5% of Vail Resorts Inc.'s common stock.

Fidelity National Financial, Inc. has disclosed beneficial ownership of 5,937,500 shares, representing 5.2% of the total voting power of Aevex Corp.'s Class A Common Stock.

Fidelity National Financial, Inc. has disclosed beneficial ownership of 5,937,500 shares, representing 5.2% of the total voting power of Aevex Corp.'s Class A Common Stock.

American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively increased their beneficial ownership of DXC Technology Company's common stock to 6.4%.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 6.2% of Alto Neuroscience, Inc. common stock, including shares issuable upon warrant exercise.

American Century Investment Management, Inc., along with its affiliates, has updated its beneficial ownership of Compass Diversified Holdings, now holding 5.4% of the common stock.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 9.74% of MoonLake Immunotherapeutics' Class A ordinary shares.

American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively disclosed beneficial ownership of over 5% of Civeo Corporation's common stock.

Deep Track Capital, LP, along with affiliated entities, has reported beneficial ownership of 3.64% of MBX Biosciences, Inc. common stock as of June 30, 2026.

Arcbest Corporation's Schedule 13G filing reveals substantial beneficial ownership by American Century entities and Stowers Institute, totaling over 12% of common stock.

Investment firm Deep Track Capital, along with its affiliates, has reported beneficial ownership of 9,341,151 shares, representing 4.55% of Immunovant, Inc.'s common stock.

American Century Investment Management, Inc. and its affiliates have reported a 6.6% beneficial ownership of Albany International Corp.'s Class A Common Stock as of June 30, 2026.